UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

British journal of cancer, 2012-03, Vol.106 (7), p.1249-1258

2012

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3965-3971

2003

Volltextzugriff (PDF)

Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling

British journal of cancer, 2010-03, Vol.102 (5), p.815-826

2010

Volltextzugriff (PDF)

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

British journal of cancer, 2008-07, Vol.99 (1), p.1-5

2008

Volltextzugriff (PDF)

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform

British journal of cancer, 2011-11, Vol.105 (10), p.1574-1581

2011

Volltextzugriff (PDF)

Variation in RNA expression and genomic DNA content acquired during cell culture

British journal of cancer, 2004-01, Vol.90 (2), p.476-482

2004

Volltextzugriff (PDF)

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

The New England journal of medicine, 2005-10, Vol.353 (16), p.1659-1672

2005

Volltextzugriff (PDF)

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

The New England journal of medicine, 2001-03, Vol.344 (11), p.783-792

2001

Volltextzugriff (PDF)

Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

British journal of cancer, 2007-07, Vol.97 (1), p.58-64

2007

Volltextzugriff (PDF)

Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer

European journal of cancer (1990), 2005-07, Vol.41 (11), p.1515-1527

2005

Volltextzugriff (PDF)

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

Journal of chemotherapy (Florence), 2007-10, Vol.19 (5), p.546-553

2007

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Journal of medicinal chemistry, 1998-07, Vol.41 (16), p.3062-3077

1998

Volltextzugriff (PDF)

Dose Scheduling – Herceptin

Oncology, 2001-01, Vol.61 (Suppl 2), p.31-36

Leyland-Jones, Brian

2001

Volltextzugriff (PDF)

Pharmacologic insights into the future of trastuzumab

Annals of oncology, 2001, Vol.12, p.43-47

2001

Volltextzugriff (PDF)

Autologous bone marrow transplantation. Current status and future directions

Annals of internal medicine, 1989-01, Vol.110 (1), p.51

1989

Volltextzugriff (PDF)

Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping

Journal of immunological methods, 2001-05, Vol.251 (1), p.1-9

2001

Volltextzugriff (PDF)

Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?

JNCI : Journal of the National Cancer Institute, 1988-09, Vol.80 (14), p.1095-1103

1988

Volltextzugriff (PDF)

Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene

Cancer research (Chicago, Ill.), 1991-01, Vol.51 (2), p.587-594

1991

Volltextzugriff (PDF)

Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications

Seminars in oncology, 2003-10, Vol.30 (5), p.174-184

LEYLANDJONES, B

2003

Volltextzugriff (PDF)

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

Drug metabolism and disposition, 1984-01, Vol.12 (1), p.9

1984

Volltextzugriff (PDF)

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Oncology, 2001-01, Vol.61 (Suppl 2), p.83-91

2001

Volltextzugriff (PDF)

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro

British journal of cancer, 1997-01, Vol.76 (4), p.467-473

1997

Volltextzugriff (PDF)

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

Antimicrobial Agents and Chemotherapy, 1985-05, Vol.27 (5), p.733-738

1985

Volltextzugriff (PDF)

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

JNCI : Journal of the National Cancer Institute, 1989-08, Vol.81 (15), p.1133-1143

1989

Volltextzugriff (PDF)

The Role of Methotrexate in Osteosarcoma

JNCI : Journal of the National Cancer Institute, 1988-07, Vol.80 (9), p.626-655

1988

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(80)

Sprache

Englisch
(80)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(79)
Humans
(73)
Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Pharmacology. Drug Treatments
(66)
Oncology
(51)
Antineoplastic Agents
(48)
Female
(32)
Chemotherapy
(26)
Drug Evaluation
(26)
Animals
(24)
General Aspects
(23)
Clinical Trials As Topic
(20)
Antineoplastic Agents - Therapeutic Use
(18)
Tumors
(17)
Adult
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Middle Aged
(16)
Neoplasms - Drug Therapy
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel

Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform

Variation in RNA expression and genomic DNA content acquired during cell culture

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Dose Scheduling – Herceptin

Pharmacologic insights into the future of trastuzumab

Autologous bone marrow transplantation. Current status and future directions

Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping

Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?

Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene

Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications

Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections

4-Ipomeanol: A Novel Investigational New Drug for Lung Cancer

The Role of Methotrexate in Osteosarcoma

Aktive Filter

Suchergebnisse filtern